Blood gas analysers and monitors

Immediate bedside results increase sales

In 2006 blood gas analysers and monitors earned manufacturers revenues of around US$360.5 million, and revenues could reach US$470 million in 2013, according to a new market report from Frost & Sullivan (F&S).

Siemens Medical Solutions RapidPoint® 400 Series
Siemens Medical Solutions RapidPoint® 400 Series

‘Laboratory tests that used to take around 30 minutes for the result to be obtained are now a thing of the past; currently manufactured point of care devices yield immediate answers,’ the report’s author, research analyst C R Hema Varshika, explained. That instant bedside capability, along with a rising patient population is, she believes, the cause of a notable sales boost. 

The main challenges for manufacturers include each country having its own purchasing system, which will only change when countries adopt uniform laws. The author attributes other problems to the high levels of brand consciousness among hospitals and ‘intense competition from local participants’. This, Ms Farshika suggests, can be overcome through innovative products and effective marketing strategies. ‘Proactive marketing of technologically advanced and user-friendly products will lead to a rise in market share,’ she then predicts.

F&S points out that this analysis - ‘The European Blood Gas Analysers and Monitors Market’ (M00B – 56) - is part of its Patient Monitoring Subscription, which includes research on: Remote Patient Monitoring and the Strategic Analysis of the European Neurological Monitoring Market.

For a virtual brochure, e-mail Radhika Menon Theodore - Corporate Communications at, giving your name, company name, title, phone number, e-address, city, state, and country.



More on the subject:
Read all latest stories

Related articles


News • Decision support system

Reducing high-risk drug combinations in the ICU

Fewer, but more relevant alerts in the ICU: Dutch researchers show how a computerized decision support system significantly reduces high-risk drug combinations in intensive care patients.


News • First human clinical trial

Pill-sized device monitors breathing from the gut

Scientists have developed an ingestible device that can safely monitor vital signs like breathing and heart rate from inside humans, providing accessible and convenient care for people at risk of…


News • Health monitoring technology

Relieving healthcare system burden with wireless biosensors

Smart catheters, smart diapers or wound dressings: a new approach to wireless biosensors from Malmö University opens up options for more patient-controlled ways of infection detection.

Related products

Subscribe to Newsletter